Human Papillomavirus (HPV) Vaccine Market Growth, Revenue Share Analysis, Company Profiles, and Forecast To 2028

The Human Papillomavirus (Hpv) Vaccine Market was valued at US$ 4,273.84 million in 2022 and is projected to reach US$ 5,730.50 million by 2028; it is expected to grow at a CAGR of 5.0% from 2022 to 2028.

Human papillomaviruses (HPV) is a diverse group of DNA-based viruses that infect the mucous and skin membranes of humans and various animals. More than 100 different types of HPV have been characterized. The increasing prevalence of various cancers caused by HPV is expected to drive the human papillomavirus (HPV) vaccine market during the forecast period. According to the Centers for Disease Control and Prevention (CDC), HPV is the most common sexually transmitted infection in the US. Over 60% of penile cancers, 70% of vulvar and vaginal cancers, and 90% of anal and cervical cancers are caused due to HPV infection. CDC also states that about 14 million people are newly infected by the virus every year in the US.

The report analyzes factors affecting Human Papillomavirus (HPV) Vaccine Market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Human Papillomavirus (HPV) Vaccine Market in these regions.

Market Segmentation:

By Type

• Bivalent
• Quadrivalent
• Nonavalent

By Indication

• Cervical Cancer
• Anal Cancer
• Penile Cancer
• Oropharyngeal Cancer
• Genital Warts
• Others 

Major Players

• Merck & Co., Inc.,
• GlaxoSmithKline plc.
• Johnson & Johnson
• Serum Institute of India Pvt. Ltd.
• Sanofi S.A.

 Recent Developments

• Market Overview and growth analysis
• Import and Export Overview
• Volume Analysis
• Current Market Trends and Future Outlook
• Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume

o Latin America Market Size and/or Volume

o Europe Market Size and/or Volume

o Asia-Pacific Market Size and/or Volume

o Rest of the world Market Size and/or Volume

The report covers the following objectives:

• Proliferation and maturation of trade in the Human Papillomavirus (Hpv) Vaccine Market .
• The market share of the global Glaucoma market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the Human Papillomavirus (Hpv) Vaccine Market .
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the Human Papillomavirus (Hpv) Vaccine Market .